Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway
- PMID: 28687357
- DOI: V体育官网入口 - 10.1016/j.canlet.2017.06.027
Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway
Erratum in
-
Corrigendum to "Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway" [Cancer Letter 403(2017) 305-317].Cancer Lett. 2022 May 28;534:215631. doi: 10.1016/j.canlet.2022.215631. Epub 2022 Mar 14. Cancer Lett. 2022. PMID: 35300896 No abstract available.
Abstract
Accumulating evidences indicate that circular RNAs (circRNAs) play a vital role in modulating gene expression. However, the mechanisms underlying circRNAs remain largely elusive. Here, we screened circRNA and mRNA expression profiles of bladder carcinoma (BC) using microarray analysis VSports手机版. We found that circRNA-MYLK and VEGFA were significantly up-regulated and co-expressed in BC. Importantly, circRNA-MYLK levels were related to the progression of stage and grade of BC. Mechanistically, we demonstrated that circRNA-MYLK could directly bind to miR-29a and relieve suppression for target VEGFA, which activated VEGFA/VEGFR2 signaling pathway. Functionally, we found that ectopically expressing circRNA-MYLK accelerated cell proliferation, migration, tube formation of HUVEC and rearranged cytoskeleton. Moreover, up-regulating circRNA-MYLK promoted epithelial-mesenchymal transition (EMT). Whereas circRNA-MYLK knockdown decreased cell proliferation, motility, and induced apoptosis. Finally, up-regulating circRNA-MYLK promoted the growth, angiogenesis and metastasis of BC xenografts. Taken together, this study demonstrated for the first time that circRNA-MYLK might function as competing endogenous RNA (ceRNA) for miR-29a, which could contribute to EMT and the development of BC through activating VEGFA/VEGFR2 and downstream Ras/ERK signaling pathway. Our data suggest that circRNA-MYLK would be a promising target for BC diagnosis and therapy. .
Keywords: Bladder cancer; VEGFA/VEGFR2 signaling pathway; ceRNA; circRNA-MYLK; miR-29a V体育安卓版. .
Copyright © 2017 Elsevier B. V. All rights reserved V体育ios版. .
MeSH terms
- "V体育安卓版" Actions
- "VSports手机版" Actions
- V体育2025版 - Actions
- Actions (V体育平台登录)
- "V体育平台登录" Actions
- "V体育平台登录" Actions
- Actions (V体育平台登录)
- "VSports" Actions
- "VSports手机版" Actions
- Actions (VSports手机版)
- "VSports手机版" Actions
- "VSports注册入口" Actions
- VSports手机版 - Actions
- VSports在线直播 - Actions
- "VSports在线直播" Actions
- Actions (V体育安卓版)
- Actions (VSports app下载)
- "VSports注册入口" Actions
Substances
- "VSports注册入口" Actions
- V体育平台登录 - Actions
- Actions (VSports在线直播)
- V体育ios版 - Actions
- "VSports" Actions
- VSports - Actions
"V体育安卓版" LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
V体育官网入口 - Miscellaneous